Which patients should we follow up beyond 5 years after definitive therapy for localized renal cell carcinoma?

Sang Hyub Lee, Hee Seo Son, Seok Cho, Sang Jin Kim, Dae Seon Yoo, Seok Ho Kang, Sung Yul Park, Jinsung Park, Sung Goo Chang, Seung Hyun Jeon

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose Up to 10% of recurrences develop beyond 5 years after curative treatment of localized renal cell carcinoma (RCC). Clinicopathologic features were evaluated to determine which factors are associated with late recurrence. Materials and Methods A total of 753 patients were diagnosed with localized RCC from January 2000 to June 2008. We enrolled 225 patients who were treated surgically and had a minimal recurrence-free survival of 60 months. Patients who had recurrence beyond 5 years after nephrectomy were defined as the late recurrence group and the remaining patients as the recurrence-free group. Multivariate logistic regression analyses and the Cox proportional hazard model were used for determination of features associated with late recurrence. Results In multivariate analyses, age older than 60 (p=0.030), Fuhrman grade ≥ 3 (p=0.042), and pT stage ≥ pT2 (p=0.010) showed statistical association with late recurrence. The Cox proportional hazard model showed significant differences in recurrence-free survival when we classified the patients based on pT2 (p=0.007) and on patient age ≥ 60 years (p=0.039). Conclusion Patient age greater than 60 years, Fuhrman grade ≥ 3, and tumor stage ≥ pT2 are independent risk factors of recurrence more than 5 years after surgery in patients with RCC. Therefore, close lifelong follow-up is recommended for patients with these risk factors.

Original languageEnglish
Pages (from-to)489-494
Number of pages6
JournalCancer Research and Treatment
Volume47
Issue number3
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Renal Cell Carcinoma
Recurrence
Therapeutics
Proportional Hazards Models
Survival
Nephrectomy
Multivariate Analysis
Logistic Models
Regression Analysis

Keywords

  • Kidney
  • Neoplasms
  • Recurrence
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Which patients should we follow up beyond 5 years after definitive therapy for localized renal cell carcinoma? / Lee, Sang Hyub; Son, Hee Seo; Cho, Seok; Kim, Sang Jin; Yoo, Dae Seon; Kang, Seok Ho; Park, Sung Yul; Park, Jinsung; Chang, Sung Goo; Jeon, Seung Hyun.

In: Cancer Research and Treatment, Vol. 47, No. 3, 01.01.2015, p. 489-494.

Research output: Contribution to journalArticle

Lee, SH, Son, HS, Cho, S, Kim, SJ, Yoo, DS, Kang, SH, Park, SY, Park, J, Chang, SG & Jeon, SH 2015, 'Which patients should we follow up beyond 5 years after definitive therapy for localized renal cell carcinoma?', Cancer Research and Treatment, vol. 47, no. 3, pp. 489-494. https://doi.org/10.4143/crt.2014.013
Lee, Sang Hyub ; Son, Hee Seo ; Cho, Seok ; Kim, Sang Jin ; Yoo, Dae Seon ; Kang, Seok Ho ; Park, Sung Yul ; Park, Jinsung ; Chang, Sung Goo ; Jeon, Seung Hyun. / Which patients should we follow up beyond 5 years after definitive therapy for localized renal cell carcinoma?. In: Cancer Research and Treatment. 2015 ; Vol. 47, No. 3. pp. 489-494.
@article{520dba38d1414dba8703aa7c15af3d61,
title = "Which patients should we follow up beyond 5 years after definitive therapy for localized renal cell carcinoma?",
abstract = "Purpose Up to 10{\%} of recurrences develop beyond 5 years after curative treatment of localized renal cell carcinoma (RCC). Clinicopathologic features were evaluated to determine which factors are associated with late recurrence. Materials and Methods A total of 753 patients were diagnosed with localized RCC from January 2000 to June 2008. We enrolled 225 patients who were treated surgically and had a minimal recurrence-free survival of 60 months. Patients who had recurrence beyond 5 years after nephrectomy were defined as the late recurrence group and the remaining patients as the recurrence-free group. Multivariate logistic regression analyses and the Cox proportional hazard model were used for determination of features associated with late recurrence. Results In multivariate analyses, age older than 60 (p=0.030), Fuhrman grade ≥ 3 (p=0.042), and pT stage ≥ pT2 (p=0.010) showed statistical association with late recurrence. The Cox proportional hazard model showed significant differences in recurrence-free survival when we classified the patients based on pT2 (p=0.007) and on patient age ≥ 60 years (p=0.039). Conclusion Patient age greater than 60 years, Fuhrman grade ≥ 3, and tumor stage ≥ pT2 are independent risk factors of recurrence more than 5 years after surgery in patients with RCC. Therefore, close lifelong follow-up is recommended for patients with these risk factors.",
keywords = "Kidney, Neoplasms, Recurrence, Renal cell carcinoma",
author = "Lee, {Sang Hyub} and Son, {Hee Seo} and Seok Cho and Kim, {Sang Jin} and Yoo, {Dae Seon} and Kang, {Seok Ho} and Park, {Sung Yul} and Jinsung Park and Chang, {Sung Goo} and Jeon, {Seung Hyun}",
year = "2015",
month = "1",
day = "1",
doi = "10.4143/crt.2014.013",
language = "English",
volume = "47",
pages = "489--494",
journal = "Cancer Research and Treatment",
issn = "1598-2998",
publisher = "Korean Society for Thoracic and Cardiovascular Surgery",
number = "3",

}

TY - JOUR

T1 - Which patients should we follow up beyond 5 years after definitive therapy for localized renal cell carcinoma?

AU - Lee, Sang Hyub

AU - Son, Hee Seo

AU - Cho, Seok

AU - Kim, Sang Jin

AU - Yoo, Dae Seon

AU - Kang, Seok Ho

AU - Park, Sung Yul

AU - Park, Jinsung

AU - Chang, Sung Goo

AU - Jeon, Seung Hyun

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Purpose Up to 10% of recurrences develop beyond 5 years after curative treatment of localized renal cell carcinoma (RCC). Clinicopathologic features were evaluated to determine which factors are associated with late recurrence. Materials and Methods A total of 753 patients were diagnosed with localized RCC from January 2000 to June 2008. We enrolled 225 patients who were treated surgically and had a minimal recurrence-free survival of 60 months. Patients who had recurrence beyond 5 years after nephrectomy were defined as the late recurrence group and the remaining patients as the recurrence-free group. Multivariate logistic regression analyses and the Cox proportional hazard model were used for determination of features associated with late recurrence. Results In multivariate analyses, age older than 60 (p=0.030), Fuhrman grade ≥ 3 (p=0.042), and pT stage ≥ pT2 (p=0.010) showed statistical association with late recurrence. The Cox proportional hazard model showed significant differences in recurrence-free survival when we classified the patients based on pT2 (p=0.007) and on patient age ≥ 60 years (p=0.039). Conclusion Patient age greater than 60 years, Fuhrman grade ≥ 3, and tumor stage ≥ pT2 are independent risk factors of recurrence more than 5 years after surgery in patients with RCC. Therefore, close lifelong follow-up is recommended for patients with these risk factors.

AB - Purpose Up to 10% of recurrences develop beyond 5 years after curative treatment of localized renal cell carcinoma (RCC). Clinicopathologic features were evaluated to determine which factors are associated with late recurrence. Materials and Methods A total of 753 patients were diagnosed with localized RCC from January 2000 to June 2008. We enrolled 225 patients who were treated surgically and had a minimal recurrence-free survival of 60 months. Patients who had recurrence beyond 5 years after nephrectomy were defined as the late recurrence group and the remaining patients as the recurrence-free group. Multivariate logistic regression analyses and the Cox proportional hazard model were used for determination of features associated with late recurrence. Results In multivariate analyses, age older than 60 (p=0.030), Fuhrman grade ≥ 3 (p=0.042), and pT stage ≥ pT2 (p=0.010) showed statistical association with late recurrence. The Cox proportional hazard model showed significant differences in recurrence-free survival when we classified the patients based on pT2 (p=0.007) and on patient age ≥ 60 years (p=0.039). Conclusion Patient age greater than 60 years, Fuhrman grade ≥ 3, and tumor stage ≥ pT2 are independent risk factors of recurrence more than 5 years after surgery in patients with RCC. Therefore, close lifelong follow-up is recommended for patients with these risk factors.

KW - Kidney

KW - Neoplasms

KW - Recurrence

KW - Renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84937159598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937159598&partnerID=8YFLogxK

U2 - 10.4143/crt.2014.013

DO - 10.4143/crt.2014.013

M3 - Article

AN - SCOPUS:84937159598

VL - 47

SP - 489

EP - 494

JO - Cancer Research and Treatment

JF - Cancer Research and Treatment

SN - 1598-2998

IS - 3

ER -